Search / 78 results found Showing: 1-10 of 78
Pfizer said Thursday it's asked the US Food and Drug Administration to authorize use of a low-dose version of its Covid-19 vaccine for children 5 to 11.
Pfizer/BioNTech plans to ask soon for authorization of a COVID-19 vaccine for some children under 12, bringing the US one step closer to offering protection to a population that has grown particularly vulnerable as the fall season gets underway.
People who are not vaccinated against COVID-19 were 11 times more likely to die of the disease and 10 times more likely to be hospitalized with the disease, a study published on Friday by the US Centers for Disease Control and Prevention shows.
With the latest COVID-19 surge upending American life yet again, an official rollout of booster doses could begin within weeks, pending FDA authorization. And it's likely that three doses of the vaccine are needed for full protection, Dr. Anthony Fauci said.
The US is surpassing an average of 160,000 new COVID-19 cases a day, according to data from Johns Hopkins University.
US health officials and medical experts announced in a joint statement on Wednesday that booster doses of Covid-19 vaccine will be offered this fall, subject to authorization from the US Food and Drug Administration and sign off from the US Centers for Disease Control and Prevention.
The US could soon see more than 200,000 new cases of COVID-19 every day as the Delta variant spreads at a rapid pace, particularly among unvaccinated people, the director of the National Institutes of Health predicted.
Doctors say it's crucial to protect children against the now-dominant Delta variant.